Breakthrough in Hepatitis C treatment


KUALA LUMPUR: In another milestone for Malaysia, a new affordable Hepatitis C combination treatment of which clinical trials have been held in the country, has shown not only a high 97% cure rate but also better efficacy of treating the most severe form of Hepatitis.

The treatment, which uses the new drug candidate ravidasvir (in combination with a generic version of sofosbuvir) has been shown to be safe and effective, with extremely high cure rates for patients, according to interim results from the Phase II/III STORM-C-1 trial.

Subscribe to The Star Yearly Premium Plan for 30% off

Cancel anytime. Ad-free. Full access to Web and App.

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.39/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Health , hepatitis c , clinical trials , drugs , treatment

Next In Nation

Malaysian all-boys group Alpha continues to impress as it goes retro with new hit "P. Ramlee & Saloma"
Two boys drowned after falling in drain in Shah Alam
PM has no plans to take disciplinary action against PKR MPs, says Fahmi
MCMC investigating individual for uploading fake content on Chief Justice's appointment
Bersih welcomes appointment of Malaysia's three top judges
Search for missing influencer in Sungai Tui called off, without new leads
Youths must be bold, financially grounded and mentally resilient to thrive in digital economy, says Dr Wee
Man caught for burying newborn baby he fathered with stepsister in Cameron Highlands
Open manhole may have caused JB van incident injuring 11 students, says exco member
National Climate Change Bill to include incentives for carbon reduction, says Johari

Others Also Read